Fund Holdings — M28 Capital Management LP

Total Portfolio Value
$58.63M
Total Bought
$0
Total Sold
$6.63M
Net Transaction
-$6.63M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
INVIVYD INC(IVVD)9,248,2509,248,25005,5986,61211.28%+1,015
FRACTYL HEALTH INC(GUTS)1,856,1171,856,11702,2093,0075.13%+798
PROQR THRAPEUTICS N V
SHS EURO
1,019,4981,019,49801,3562,0803.55%+724
SILENCE THERAPEUTICS PLC(SLN)185,100185,10005221,0741.83%+552
ARROWHEAD PHARMACEUTICALS IN(ARWR)67,40067,40008591,0651.82%+206
CURIS INC(CRIS)521,059521,05901,0941,2092.06%+115
TG THERAPEUTICS INC(TGTX)161,600161,60006,3725,8169.92%-556
ROCKET PHARMACEUTICALS INC(RCKT)385,680385,68002,5729451.61%-1,628
SPRINGWORKS THERAPEUTICS INC55,2000-55,2002,4360—-2,436
BRIDGEBIO PHARMA INC(BBIO)121,2000-121,2004,1900—-4,190
WAVE LIFE SCIENCES LTD(WVE)5,664,5485,664,548045,77036,82062.80%-8,950
Page 1 of 1
M28 Capital Management LP — 13F Holdings — Q2 2025 | TickerTrail